| Trial ID: | L1909 |
| Source ID: | NCT06169982
|
| Associated Drug: |
Ly3209590
|
| Title: |
A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: LY3209590
|
| Outcome Measures: |
Primary: Pharmacokinetics (PK): Area under the concentration curve during one dosing interval at steady state (AUCss) of LY3209590, PK: AUCss of LY3209590, One dosing interval at steady state from 0 to 168 hours after last dose | Secondary: PK: Total amount of glucose infused during one dosing interval at steady state (Gtot,SS) of LY3209590, PK: Gtot,SS of LY3209590, One dosing interval at steady state from 0 to 168 hours after last dose
|
| Sponsor/Collaborators: |
Sponsor: Eli Lilly and Company
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
56
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2023-12-07
|
| Completion Date: |
2024-07-18
|
| Results First Posted: |
|
| Last Update Posted: |
2024-09-04
|
| Locations: |
Profil Institut für Stoffwechselforschung, Neuss, Nordrhein-Westfalen, 41460, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT06169982
|
